Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endometrial malignancy.

A Pfleiderer1

  • 1Albert-Ludwigs-Universität, Freiburg, Germany.

Current Opinion in Obstetrics & Gynecology
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Endometrial carcinoma has two types: favorable and unfavorable prognosis. Fertility-preserving treatment is possible for young patients with well-differentiated types, while high-risk patients may benefit from radiotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AUTHORS' RESPONSE.

Annals of the Royal College of Surgeons of England·2016
Same author

The value and role of low dose methylene blue in the surgical management of hyperparathyroidism.

Annals of the Royal College of Surgeons of England·2014
Same author

RETRACTED ARTICLE: Culturomics identified 11 new bacterial species from a single anorexia nervosa stool sample.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013
Same author

Intratympanic gentamicin treatment for unilateral Ménière's disease: long-term follow up of a proven regime.

The Journal of laryngology and otology·2012
Same author

Caliper measurement to improve clinical assessment of palpable neck lumps.

Annals of the Royal College of Surgeons of England·2012
Same author

Fibroepithelial polyp of the tonsil: case report of a rare, benign tonsillar lesion.

The Journal of laryngology and otology·2009
Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026
Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026
Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026
Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026
See all related articles

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Radiotherapy

Background:

  • Endometrial carcinoma classification and prognosis.
  • Review of published literature from August 1989 to July 1990.
  • Established hypothesis of two distinct pathogenic types with differing prognoses.

Purpose of the Study:

  • To review current knowledge on endometrial carcinoma.
  • To correlate clinicopathological factors with prognosis.
  • To evaluate treatment strategies for different risk groups.

Main Methods:

  • Literature review of published papers.
  • Analysis of prognostic factors measurable preoperatively (curettage, sonography, MRI).
  • Intraoperative assessment via frozen-section diagnosis.

Related Experiment Videos

Main Results:

  • Well-differentiated endometrial carcinoma in young patients (<21 years) has an excellent prognosis, allowing fertility-sparing treatment.
  • Prognostic factors are identifiable preoperatively.
  • Percutaneous radiotherapy is indicated for high-risk patients postoperatively.
  • Vaginal irradiation causes local complaints; adjuvant progestagen therapy is potentially dangerous and ineffective.

Conclusions:

  • Accurate preoperative staging and risk stratification are crucial for optimal treatment selection.
  • Adjuvant chemotherapy and progestagen therapy show limited benefit.
  • Further research into luteinizing hormone-releasing hormone receptor-targeted therapies may be warranted.